GeneDx Holdings Corp.
Kevin Feeley (CHIEF FINANCIAL OFFICER) sells WGS shares
About this filing
GeneDx Holdings Corp. (WGS) filed Form 4 (insider transaction) with the SEC on Sep 3, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Kevin Feeley · CHIEF FINANCIAL OFFICER
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +717 | $0.00 | $0.00 | 40,671 | Direct |
| Sep 1, 2026 | S · open-market saleFootnotes F2, F3, F4 | −372 | $83.84 | $31,188.11 | 40,299 | Direct |
| Sep 1, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitFootnotes F1, F5 | −717 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.71 to $83.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 40,299 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 81,326 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
- F5 6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
More WGS filings
- 4
Filed Sep 18, 2026
- 4
Filed Sep 18, 2026
- 4
Filed Sep 18, 2026
- 4
Filed Sep 11, 2026
- 4
Filed Sep 11, 2026
- 144
Filed Sep 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.